Hims & Hers Health director converts awards to 810 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. director Christopher D. Payne reported an RSU-to-share conversion involving 810 RSUs and 810 Class A common shares on November 13, 2026; his direct holdings afterward were 35,673 shares. The accompanying note says the RSUs were granted in lieu of $23,125 in third-quarter 2026 director retainer fees, calculated using a $28.53 grant price, and will vest in full on the company’s next quarterly vesting date. A separate holding entry lists 110,000 Class A shares held by The Payne Family Trust dtd 09/17/2020.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1 | 810 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 810 | -- | -- |
| Holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,125 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.
Key Figures
Key Terms
Restricted Stock Units technical
Director Compensation Policy financial
grant price financial
quarterly vesting date technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.